357 related articles for article (PubMed ID: 27892889)
1. The impact of functional vs degenerative mitral regurgitation on clinical outcomes among patients undergoing transcatheter aortic valve implantation.
Vollenbroich R; Stortecky S; Praz F; Lanz J; Franzone A; Zuk K; Heg D; Valgimigli M; O'Sullivan CJ; Heinisch C; Roost E; Wenaweser P; Windecker S; Pilgrim T
Am Heart J; 2017 Feb; 184():71-80. PubMed ID: 27892889
[TBL] [Abstract][Full Text] [Related]
2. Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
O'Sullivan CJ; Stortecky S; Bütikofer A; Heg D; Zanchin T; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Blöchlinger S; Carrel T; Meier B; Zbinden S; Wenaweser P; Windecker S
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001895. PubMed ID: 25657315
[TBL] [Abstract][Full Text] [Related]
3. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry.
Freitas-Ferraz AB; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto WY; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Annabi MS; Pelletier-Beaumont E; Pibarot P; Rodés-Cabau J
JACC Cardiovasc Interv; 2020 Mar; 13(5):567-579. PubMed ID: 32061600
[TBL] [Abstract][Full Text] [Related]
4. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.
Zahn R; Werner N; Gerckens U; Linke A; Sievert H; Kahlert P; Hambrecht R; Sack S; Abdel-Wahab M; Hoffmann E; Zeymer U; Schneider S;
Heart; 2017 Dec; 103(24):1970-1976. PubMed ID: 28684438
[TBL] [Abstract][Full Text] [Related]
5. Tricuspid but not Mitral Regurgitation Determines Mortality After TAVI in Patients With Nonsevere Mitral Regurgitation.
Amat-Santos IJ; Castrodeza J; Nombela-Franco L; Muñoz-García AJ; Gutiérrez-Ibanes E; de la Torre Hernández JM; Córdoba-Soriano JG; Jiménez-Quevedo P; Hernández-García JM; González-Mansilla A; Ruano J; Tobar J; Del Trigo M; Vera S; Puri R; Hernández-Luis C; Carrasco-Moraleja M; Gómez I; Rodés-Cabau J; San Román JA
Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):357-364. PubMed ID: 29079280
[TBL] [Abstract][Full Text] [Related]
6. Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement.
Kindya B; Ouzan E; Lerakis S; Gonen E; Babaliaros V; Karayel E; Thourani VH; Gotsman I; Devireddy CM; Danenberg HD; Leshnower BG; Beeri R; Ko YA; Gilon D; Ahmed H; Liu C; Lotan C; Mavromatis K
Catheter Cardiovasc Interv; 2018 Sep; 92(3):574-582. PubMed ID: 29602220
[TBL] [Abstract][Full Text] [Related]
7. Impact of Functional Versus Organic Baseline Mitral Regurgitation on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Replacement.
Kiramijyan S; Koifman E; Asch FM; Magalhaes MA; Didier R; Escarcega RO; Negi SI; Baker NC; Jerusalem ZD; Gai J; Torguson R; Okubagzi P; Wang Z; Shults CC; Ben-Dor I; Corso PJ; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2016 Mar; 117(5):839-46. PubMed ID: 26873331
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter aortic valve implantation in patients with concomitant mitral and tricuspid regurgitation.
Hutter A; Bleiziffer S; Richter V; Opitz A; Hettich I; Mazzitelli D; Ruge H; Lange R
Ann Thorac Surg; 2013 Jan; 95(1):77-84. PubMed ID: 23063197
[TBL] [Abstract][Full Text] [Related]
9. Impact of baseline mitral regurgitation on short- and long-term outcomes following transcatheter aortic valve replacement.
Kiramijyan S; Magalhaes MA; Koifman E; Didier R; Escarcega RO; Minha S; Baker NC; Negi SI; Torguson R; Gai J; Okubagzi P; Asch FM; Gaglia MA; Ben-Dor I; Satler LF; Pichard AD; Waksman R
Am Heart J; 2016 Aug; 178():19-27. PubMed ID: 27502848
[TBL] [Abstract][Full Text] [Related]
10. Interplay between mitral regurgitation and transcatheter aortic valve replacement with the CoreValve Revalving System: a multicenter registry.
Bedogni F; Latib A; De Marco F; Agnifili M; Oreglia J; Pizzocri S; Latini RA; Lanotte S; Petronio AS; De Carlo M; Ettori F; Fiorina C; Poli A; Cirri S; De Servi S; Ramondo A; Tarantini G; Marzocchi A; Fiorilli R; Klugmann S; Ussia GP; Tamburino C; Maisano F; Brambilla N; Colombo A; Testa L
Circulation; 2013 Nov; 128(19):2145-53. PubMed ID: 24088530
[TBL] [Abstract][Full Text] [Related]
11. Is isolated aortic valve replacement sufficient to treat concomitant moderate functional mitral regurgitation? A propensity-matched analysis.
Sorabella RA; Olds A; Yerebakan H; Hassan D; Borger MA; Argenziano M; Smith CR; George I
J Cardiothorac Surg; 2018 Jun; 13(1):72. PubMed ID: 29921286
[TBL] [Abstract][Full Text] [Related]
12. Fate and long-term prognostic implications of mitral regurgitation in patients undergoing transcatheter aortic valve replacement.
Abdelghani M; Abdel-Wahab M; Hemetsberger R; Landt M; Merten C; Toelg R; Richardt G
Int J Cardiol; 2019 Aug; 288():39-43. PubMed ID: 30948219
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effects of TAVI in mitral insufficiency.
Costantino MF; Dores E; Innelli P; Matera A; Santillo V; Violini R; Fiorilli R; Cappabianca G; Marraudino N; Picano E; Tarsia G
Cardiovasc Ultrasound; 2015 Dec; 13():49. PubMed ID: 26714887
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter aortic valve implantation reduces grade of concomitant mitral and tricuspid valve regurgitation and pulmonary hypertension.
Wilbring M; Tugtekin SM; Ritzmann M; Arzt S; Schmidt T; Matschke K; Kappert U; Alexiou K
Eur J Cardiothorac Surg; 2014 Nov; 46(5):818-24. PubMed ID: 24574441
[TBL] [Abstract][Full Text] [Related]
15. Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation.
D'Onofrio A; Gasparetto V; Napodano M; Bianco R; Tarantini G; Renier V; Isabella G; Gerosa G
Eur J Cardiothorac Surg; 2012 Jun; 41(6):1271-6; discussion 1276-7. PubMed ID: 22219481
[TBL] [Abstract][Full Text] [Related]
16. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement.
Ruel M; Kapila V; Price J; Kulik A; Burwash IG; Mesana TG
Circulation; 2006 Jul; 114(1 Suppl):I541-6. PubMed ID: 16820634
[TBL] [Abstract][Full Text] [Related]
17. Mitral regurgitation prior to transcatheter aortic valve implantation influences survival but not symptoms.
Boerlage-van Dijk K; Wiegerinck EM; Takama T; Koch KT; Vis MM; de Mol BA; Piek JJ; Bouma BJ; Baan J
Int J Cardiol; 2016 Feb; 204():95-100. PubMed ID: 26655549
[TBL] [Abstract][Full Text] [Related]
18. Change in mitral regurgitation severity impacts survival after transcatheter aortic valve replacement.
Feldt K; De Palma R; Bjursten H; Petursson P; Nielsen NE; Kellerth T; Jönsson A; Nilsson J; Rück A; Settergren M
Int J Cardiol; 2019 Nov; 294():32-36. PubMed ID: 31399298
[TBL] [Abstract][Full Text] [Related]
19. The MitraClip Asia-Pacific registry: Differences in outcomes between functional and degenerative mitral regurgitation.
Tay E; Muda N; Yap J; Muller DW; Santoso T; Walters DL; Liu X; Yamen E; Jansz P; Yip J; Zambahari R; Passage J; Ding ZP; Wang J; Scalia G; Soesanto AM; Yeo KK
Catheter Cardiovasc Interv; 2016 Jun; 87(7):E275-81. PubMed ID: 26508564
[TBL] [Abstract][Full Text] [Related]
20. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.
Barbanti M; Webb JG; Hahn RT; Feldman T; Boone RH; Smith CR; Kodali S; Zajarias A; Thompson CR; Green P; Babaliaros V; Makkar RR; Szeto WY; Douglas PS; McAndrew T; Hueter I; Miller DC; Leon MB;
Circulation; 2013 Dec; 128(25):2776-84. PubMed ID: 24152861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
